Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users

Objectives. A once-daily, extended-release hydrocodone bitartrate tablet with abuse-deterrent properties (Hysingla ER® [HYD]) is available for the treatment of chronic pain in appropriate patients. This study evaluated the intranasal abuse potential and pharmacokinetics of HYD coarse and fine partic...

Full description

Saved in:
Bibliographic Details
Published in:Pain Med
Main Authors: Harris, Stephen C., Cipriano, Alessandra, Colucci, Salvatore V., Kapil, Ram P., Geoffroy, Pierre, Hopyan, Talar, Levy-Cooperman, Naama
Format: Artigo
Language:Inglês
Published: Oxford University Press 2016
Subjects:
GENERAL SECTION
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4984427/
https://ncbi.nlm.nih.gov/pubmed/26814240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pm/pnv004
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items